Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

am distributions (yorkshire) ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

j m mcgill ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

niche pharma ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

cst pharma ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

cubic pharmaceuticals ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

colorama pharmaceuticals ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Velká Británie - angličtina - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - metronidazole - cutaneous gel - 7.5mg/1gram

Spojené státy - angličtina - NLM (National Library of Medicine)

sandoz inc. - metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e) - metronidazole 7.5 mg in 1 g - metronidazole vaginal gel usp, 0.75% is indicated in the treatment of bacterial vaginosis (formerly referred to as haemophilus vaginitis, gardnerella vaginitis, nonspecific vaginitis, corynebacterium vaginitis, or anaerobic vaginosis). - note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with a 10% koh solution, and (c) contains clue cells on microscopic examination. gram’s stain results consistent with a diagnosis of bacterial vaginosis include (a) markedly reduced or absent lactobacillus morphology, (b) predominance of gardnerella morphotype, and (c) absent or few white blood cells. note: for purposes of this indication, a clinical diagnosis of bacterial vaginosis is usually defined by the presence of a homogeneous vaginal discharge that (a) has a ph of greater than 4.5, (b) emits a “fishy” amine odor when mixed with